# FDA recall D-502-2013

> **Hospira Inc.** · Class II · drug recall initiated 2013-04-30.

## Product

DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32

## Reason for recall

Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.

## Distribution

Nationwide  and Puerto Rico

## Key facts

- **Recall number:** D-502-2013
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-30
- **Report date:** 2013-06-12
- **Termination date:** 2014-10-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-502-2013

## Citation

> AI Analytics. FDA recall D-502-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-502-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*